241 related articles for article (PubMed ID: 19156541)
21. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
Zhang Y; Li H; Hao J; Zhou Y; Liu W
Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698
[TBL] [Abstract][Full Text] [Related]
22. N-acetylcysteine prevents beta-amyloid toxicity by a stimulatory effect on p35/cyclin-dependent kinase 5 activity in cultured cortical neurons.
Hsiao YH; Chen PS; Yeh SH; Lin CH; Gean PW
J Neurosci Res; 2008 Sep; 86(12):2685-95. PubMed ID: 18512759
[TBL] [Abstract][Full Text] [Related]
23. Actin interaction and regulation of cyclin-dependent kinase 5/p35 complex activity.
Xu J; Tsutsumi K; Tokuraku K; Estes KA; Hisanaga S; Ikezu T
J Neurochem; 2011 Jan; 116(2):192-204. PubMed ID: 20492361
[TBL] [Abstract][Full Text] [Related]
24. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
[TBL] [Abstract][Full Text] [Related]
25. Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.
Schmid G; Strosznajder JB; Wesierska-Gadek J
Mol Neurobiol; 2006 Aug; 34(1):27-50. PubMed ID: 17003520
[TBL] [Abstract][Full Text] [Related]
26. Resveratrol inhibits Cdk5 activity through regulation of p35 expression.
Utreras E; Terse A; Keller J; Iadarola MJ; Kulkarni AB
Mol Pain; 2011 Jul; 7():49. PubMed ID: 21736731
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of p35 in Min6 pancreatic beta cells induces a stressed neuron-like apoptosis.
Zheng YL; Hu YF; Zhang A; Wang W; Li B; Amin N; Grant P; Pant HC
J Neurol Sci; 2010 Dec; 299(1-2):101-7. PubMed ID: 20926102
[TBL] [Abstract][Full Text] [Related]
28. Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia.
Bosutti A; Qi J; Pennucci R; Bolton D; Matou S; Ali K; Tsai LH; Krupinski J; Petcu EB; Montaner J; Al Baradie R; Caccuri F; Caruso A; Alessandri G; Kumar S; Rodriguez C; Martinez-Gonzalez J; Slevin M
PLoS One; 2013; 8(9):e75538. PubMed ID: 24098701
[TBL] [Abstract][Full Text] [Related]
29. Cdk5 interacts with Hif-1α in neurons: a new hypoxic signalling mechanism?
Antoniou X; Gassmann M; Ogunshola OO
Brain Res; 2011 Mar; 1381():1-10. PubMed ID: 20977891
[TBL] [Abstract][Full Text] [Related]
30. Metformin inhibits nerve growth factor-induced sympathetic neuron differentiation through p35/CDK5 inhibition.
Oner M; Chen MC; Cheng PT; Lin H
Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1648-C1658. PubMed ID: 38682237
[TBL] [Abstract][Full Text] [Related]
31. Valproic acid downregulates Cdk5 activity via the transcription of the p35 mRNA.
Takahashi M; Ishida M; Saito T; Ohshima T; Hisanaga S
Biochem Biophys Res Commun; 2014 May; 447(4):678-82. PubMed ID: 24755075
[TBL] [Abstract][Full Text] [Related]
32. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain.
Wang WY; Luo Y; Jia LJ; Hu SF; Lou XK; Shen SL; Lu H; Zhang HH; Yang R; Wang H; Ma ZW; Xue QS; Yu BW
Neuropharmacology; 2014 Feb; 77():90-9. PubMed ID: 24055498
[TBL] [Abstract][Full Text] [Related]
34. Wnt-5a Promotes Neural Development and Differentiation by Regulating CDK5 via Ca2+/Calpain Pathway.
Shu Y; Xiang M; Zhang P; Qi G; He F; Zhang Q; Zhang Z; Lv Z; Peng X; Cai H; Tian B
Cell Physiol Biochem; 2018; 51(6):2604-2615. PubMed ID: 30562750
[TBL] [Abstract][Full Text] [Related]
35. Cyclin-dependent kinase 5 activity regulates pain signaling.
Pareek TK; Keller J; Kesavapany S; Pant HC; Iadarola MJ; Brady RO; Kulkarni AB
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):791-6. PubMed ID: 16407116
[TBL] [Abstract][Full Text] [Related]
36. Cyclin-dependent kinase 5 modulates the P2X2a receptor channel gating through phosphorylation of C-terminal threonine 372.
Coddou C; Sandoval R; Castro P; Lazcano P; Hevia MJ; Rokic M; Hall B; Terse A; Gonzalez-Billault C; Kulkarni AB; Stojilkovic SS; Utreras E
Pain; 2017 Nov; 158(11):2155-2168. PubMed ID: 28809765
[TBL] [Abstract][Full Text] [Related]
37. Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells.
Lin H; Chen MC; Chiu CY; Song YM; Lin SY
J Biol Chem; 2007 Feb; 282(5):2776-84. PubMed ID: 17145757
[TBL] [Abstract][Full Text] [Related]
38. Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE.
Hosokawa T; Saito T; Asada A; Fukunaga K; Hisanaga S
Mol Cell Proteomics; 2010 Jun; 9(6):1133-43. PubMed ID: 20097924
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
[TBL] [Abstract][Full Text] [Related]
40. Calpain-2/p35-p25/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated diphenyl ether-153.
Zhang H; Chang L; Zhang H; Nie J; Zhang Z; Yang X; Vuong AM; Wang Z; Chen A; Niu Q
Toxicol Lett; 2017 Aug; 277():41-53. PubMed ID: 28559121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
